In-house viral and plasmid stocks ready the next day
About the Vector Core
The Vector Core produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions, and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community. The specific objectives of the Vector Core are to:
- Provide a Core laboratory for the construction, purification, and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies;
- Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies;
- Maintain qualified staff and provide high quality, cost-effective products to our researchers.
To begin work with the Vector Core, you will first need to register with MiCores and complete training. Please see the Training page for more information on how to get started.
For questions regarding your specific needs or project goals please contact Vector Core Director, Tom Lanigan, to set up a consultation.
Vector Core by the Numbers
Principal Investigators Worked With (FY17)
Grants Serviced (FY17)
2018 Biomedical Research Core Facilities Holiday Hours
As in past years, many staff in the Biomedical Research Core Facilities will be using University Season Days between December 25 and January 1. The schedule for the individual Cores during the holidays is given below. Bioinformatics Core (B22 NCRC): Services …Event
The DNA Sequencing Core Welcomes New Leadership
A Message from Steve Kunkel, Ph.D., Interim Chief Scientific Director, and BRCF Leadership We are pleased to announce that Thomas Wilson MD, Ph.D., Professor of Pathology and Human Genetics, and Olivia Koues, Ph.D., have joined the University of Michigan Medical …Breaking News
In Focus: U-M Kidney Research Collaboration Works to Discover New Ways to Treat Kidney Disease
Featuring Dr. Matthias Kretzler; Warner-Lambert/Parke-Davis Professor of Medicine, Professor of Internal Medicine and Research Professor, Computation Medicine and Bioinformatics Chronic kidney disease (CKD), the progressive decline in kidney function, affects nearly 30 million Americans, with millions of others at increased risk …Research Profiles